At the oncological level, IGFBP3 could also have a relevant role in lung cancer, especially in relation to cancer stem cells.

The study identifies mechanisms by which drug-resistant lung cancer cells alter the tumor microenvironment, leading to cancer recurrence and reduced efficacy of targeted therapies.